IMDX — Insight Molecular Diagnostics Inc.

—
Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1642380 ·
Last close
$1.66
Market Cap
$54.32M
52W High
$7.51
52W Low
$1.50
ADV30
237,357
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 239,000 157,000 -9,088,000 -11,260,000 29,443,000 17,756,000 50,742,000
Mar 2026 32,000 15,000 -10,331,000 -4,290,000 40,427,000 28,201,000 51,118,000
Dec 2025 1,139,000 496,000 -9,950,000 -22,955,000 25,756,000 11,583,000 57,220,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-27,078,000
Investing CF
$-3,921,000
Financing CF
$23,762,000
CapEx
$-3,921,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.49
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-416,311,000
Inventory
$207,000
Receivables
$192,000
ST Investments
—
EBIT TTM
$-49,261,000
Pretax Income TTM
$-49,359,000
Interest Exp TTM
$98,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,670,000
EBITDA
$-34,543,000
Free Cash Flow
$-18,789,500
Enterprise Value
$122,310,992
Total Cash
$17,756,000
Total Debt
$2,625,000
Shares Out
32,724,284
Trailing EPS
$-1.52
Book Value
$-0.65
ROE
—
ROA
-57.8%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,055,000 -30,578,000 -50,222,000 25,756,000 57,220,000 -31,464,000 -22,184,000
Dec 2024 1,881,000 -23,247,000 -60,663,000 35,081,000 47,355,000 -12,274,000 -20,689,000
Dec 2023 1,503,000 -22,417,000 -27,781,000 74,892,000 54,424,000 20,468,000 -23,325,000
Dec 2022 958,000 -28,852,000 -72,902,000 100,091,000 65,799,000 34,292,000 -45,568,000

TTM Snapshot

Revenues TTM
$1,670,000
NetIncome TTM
$-49,359,000
OpCashFlow TTM
—
Assets (Latest)
$29,443,000
Forward EPS
$-0.80

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.00 · spot: $1.66 · call volume: 14 · put volume: 5
Expected Move to 2026-12-18: ±$3.40 (204.82%) — implied range $-1.74 – $5.06 · ATM straddle on $2.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
IBAC IB Acquisition Corp. $54.33M $10.85 —
ICCC IMMUCELL CORP /DE/ $101.55M $11.17 —
MXCT MAXCYTE, INC. $132.16M $1.28 —
NNNN Anbio Biotechnology $160.20M $3.65 —
ONMD OneMedNet Corp $267.38M $4.51 —

News headlines (Yahoo Finance, 1h cache)

Insight Molecular Diagnostics (IMDX) Stock Sees Fair Value Cut As FDA Questions Cloud Analyst Views
2026-11-20 01:13 · Yahoo
Insight Molecular (IMDX) Q3 2026 Earnings Call Transcript
2026-11-17 16:28 · Yahoo
Insight Molecular Diagnostics Inc. Q3 2026 Earnings Call Summary
2026-11-17 13:30 · Yahoo
Insight Molecular Diagnostics Announces Pricing of $15 Million Public Offering
2026-11-17 13:00 · Yahoo
Insight Molecular Diagnostics: Q3 Earnings Snapshot
2026-11-16 22:47 · Yahoo
Insight Molecular Diagnostics stock tumbles on public offering
2026-11-16 22:43 · Yahoo
IMDx Reports Third Quarter 2026 Results and Provides Corporate Update
2026-11-16 21:56 · Yahoo
Insight Molecular Diagnostics Announces Proposed Public Offering
2026-11-16 21:10 · Yahoo
iMDx to Release Third Quarter Results on November 16, 2026
2026-11-05 12:00 · Yahoo
iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
2026-10-14 12:00 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-11-19 17:58:07 2026-11-17 Broadwood Partners, L.P. 10% P - Purchase 1.75 3428571 5999999